Enrique A. Conterno - 08 Mar 2023 Form 4/A - Amendment Insider Report for FIBROGEN INC (FGEN)

Role
Chief Executive Officer, Director
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Issuer symbol
FGEN
Transactions as of
08 Mar 2023
Net transactions value
-$393,625
Form type
4/A - Amendment
Filing time
23 Mar 2023, 16:50:07 UTC
Date Of Original Report
10 Mar 2023
Previous filing
23 Feb 2023
Next filing
11 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale $393,625 -19,489 -4.8% $20.20* 384,868 10 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.

Remarks:

This From 4/A is being filed to correct the number of shares sold in column 4.